Alnylam Pharmaceuticals
ALNY
#485
Rank
HK$382.27 B
Marketcap
HK$2,894
Share price
-6.87%
Change (1 day)
43.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company